Showing results (141-150 of 149) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.Nature Communications|April 4, 2025
Probing the subtle differences between promethium and curiumTrenton B Vogt, Megan E Simms, Connor J Parker, et al.Chemical Science|July 26, 2024
PYTA: a universal chelator for advancing the theranostic palette of nuclear medicineMegan E Simms, Zhiyao Li, Megan M Sibley, et al.Cell Metabolism|February 21, 2017
Excessive Respiratory Modulation of Blood Pressure Triggers HypertensionClément Menuet, Sheng Le, Bowen Dempsey, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.Biochemistry|November 12, 2013
Biochemical and kinetic characterization of radical S-adenosyl-L-methionine enzyme HydGRebecca C Driesener, Benjamin R Duffus, Eric M Shepard, et al.Angewandte Chemie (International Ed. in English)|January 29, 2025
Towards the Stable Chelation of Radioantimony(V) for Targeted Auger TheranosticsAeli P Olson, Briana R Schrage, Md Faizul Islam, et al.Journal of Leukocyte Biology|February 28, 2016
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityTimothy T Spear, Timothy P Riley, Gretchen E Lyons, et al.Pageof 15